Axonics, Inc. (AXNX)
NASDAQ: AXNX · IEX Real-Time Price · USD
68.49
+0.30 (0.44%)
At close: Jul 26, 2024, 4:00 PM
68.61
+0.12 (0.18%)
After-hours: Jul 26, 2024, 6:35 PM EDT

Axonics Revenue

Axonics had revenue of $91.41M in the quarter ending March 31, 2024, with 29.38% growth. This brings the company's revenue in the last twelve months to $387.14M, up 30.82% year-over-year. In the year 2023, Axonics had annual revenue of $366.38M with 33.86% growth.

Revenue (ttm)
$387.14M
Revenue Growth
+30.82%
P/S Ratio
9.03
Revenue / Employee
$485,744
Employees
797
Market Cap
3.49B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023366.38M92.68M33.86%
Dec 31, 2022273.70M93.41M51.81%
Dec 31, 2021180.29M68.76M61.64%
Dec 31, 2020111.54M97.72M707.05%
Dec 31, 201913.82M13.11M1,854.74%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Prestige Consumer Healthcare 1.13B
GoodRx Holdings 764.16M
Denali Therapeutics 295.39M
Twist Bioscience 277.49M
Arcellx 131.66M
Alvotech 114.39M
Merus 38.34M
Arrowhead Pharmaceuticals 35.47M
Revenue Rankings